EXOZ Latest Press Releases

-- September 8, 2026 --

eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT ACCESS Newswire 10:20 AM

-- August 20, 2026 --

eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today ACCESS Newswire 4:10 PM

-- August 18, 2026 --

eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets ACCESS Newswire 4:30 PM

-- August 13, 2026 --

MDB Capital Holdings Provides Second Quarter 2026 Update Globe Newswire 4:05 PM

-- August 11, 2026 --

eXoZymes to Host Second Quarter 2026 Update Conference Call on Thursday, August 20, 2026 ACCESS Newswire 4:10 PM

-- July 23, 2026 --

eXoZymes Selected for DoE's Genesis Mission to Advance AI-Powered Digital Twins for Cell-Free Biomanufacturing ACCESS Newswire 4:15 PM

-- June 24, 2026 --

eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery ACCESS Newswire 4:10 PM

-- June 17, 2026 --

eXoZymes Inc. Announces Closing of $6 Million Public Offering ACCESS Newswire 4:10 PM

-- June 8, 2026 --

eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants ACCESS Newswire 9:00 AM

-- May 7, 2026 --

eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program ACCESS Newswire 9:05 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software